Oxfendazole API Intermediates Cas 53716-50-0

Oxfendazole API Intermediates Cas 53716-50-0

Oxfendazole API Intermediates Cas 53716-50-0 is a new broad-spectrum anthelmintic drug, which is more than twice as effective as phenylthiobenzimidazole. It is administered to various gastrointestinal nematode adults of sheep, cattle and pigs at a dose of 23.5-5mg/kg.

Chat Now

Product Details

Oxfendazole API Intermediates Cas 53716-50-0

Oxfendazole is a new broad-spectrum anthelmintic drug, which is more than twice as effective as phenylthiobenzimidazole. It is administered to various gastrointestinal nematode adults of sheep, cattle and pigs at a dose of 23.5-5mg/kg. The insect reduction rate is 95-100%. The worm reduction rate for each stage of larvae was 91-98%. It is also effective against short-shelled aphids and nematodes, but it is less effective against pig whipworms. This product has low toxicity and good tolerance.


Basic Info.

Appearance and traits: white to light yellow powder

Density: 1.5g/cm3

Melting point: 253oC

Refractive index: 1.735

Storage conditions: 2-8oC

Category: API

CAS NO: 53716-50-0

EC NO: 258-714-5

Molecular Formula: C15H13N3O3S

Molecular Weight: 315.347

Specification: EP/USP


InChI: InChI=1/C15H13N3O3S/c1-21-15(19)18-14-16-12-8-7-11(9-13(12)17-14)22(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,16,17,18,19)

Synonyms:

methyl N-[5-(benzenesulfinyl)-3H-benzoimidazol-2-yl]carbamate;

methyl [6-(phenylsulfinyl)-1H-benzimidazol-2-yl]carbamate;

[5-(phenylsulfinyl)-1h-benzimidazol-2-yl]carbamic acid methyl ester;


Molecular Structure:

medicine interactions

This product is the same as fenbendazole, and can not be used together with the mitochondrial bromide, otherwise it will cause sheep death and abortion.

Note:

The palatability of the raw materials of this product is poor. If the raw materials are mixed, care should be taken to prevent the loss of food intake and the lack of medicine to affect the insect repellent effect.

Previous:No Information Next:Progesterone API Intermediates Cas 57-83-0

Inquiry